HopeStage
Back to all studies
CompletedNCT00282464

A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.

Medication studyAges 18+United StatesBipolarity
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Dothan and 42 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study clarity

Study information

Study start dateFebruary 2006
Recruitment status
Completed
Enrollment listed in the registry
392
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT00282464
Official title
Show the full official title

A Six-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Flexible Doses of Oral Ziprasidone in Outpatients With Bipolar I Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Dothan · Little Rock · Anaheim

39 more locations
  • Cerritos
  • Chula Vista
  • Escondido
  • Los Angeles
  • Riverside
  • San Diego
  • Santa Ana
  • Denver
  • Darien
  • Boca Raton
  • Bradenton
  • Jacksonville
  • Melbourne
  • Orange City
  • Tampa
  • Atlanta
  • Marietta
  • Eagle
  • Granite City
  • Terre Haute
  • Glen Burnie
  • Towson
  • Rochester
  • St Louis
  • Princeton
  • Brooklyn
  • New York
  • Olean
  • Durham
  • Raleigh
  • Toledo
  • Tulsa
  • Philadelphia
  • Scranton
  • Lincoln
  • Dallas
  • Houston
  • San Antonio
  • Charlottesville
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Did this study involve medication?

Yes. The study involved medication, including Placebo and Geodon (Ziprasidone).

Who was this study for?

Listed age limits: from 18 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me